TABLE 3.
Characteristics of included studies in the narrative synthesis of mortality predictors among PLWH on induction therapy in Africa, 1998–2018.
| Author | Year | Country | Sample size | Study design | % Men | Median/mean age | Median CD4 cells/mm3 | ART history | CM diagnosis confirmed by | Treatment | % death |
| Luma et al. (37) | 2013 | Cameroon | 672 | CS | 57.3 | 36.9 | 23 | No data | India Ink/CT | Fluconazole | 5.8 |
| Patel et al. (4) | 2018 | Botswana | 236 | C | 69 | 36 | 39 | 57% | India Ink/CSF CRAG/CSF Culture | Amphotericin, Fluconazole | 67.3 |
| Nussbaum et al. (46) | 2010 | Malawi | 41 | RCT | 66 | 36 | 21 | All naïve | India Ink/CSF CRAG/CSF Culture | Fluconazole, Flucytosine | 48.8 |
| Kizza et al. (47) | 1998 | Uganda | 58 | RCT | 47 | 34 | 77 | No data | India Ink/CSF CRAG/SCF Culture | Fluconazole, Flucytosine | 46.6 |
| Longley et al. (48) | 2008 | Uganda | 60 | C | 57 | 34 | 12 | All naïve | India Ink/CSF Culture | Fluconazole | 51.7 |
| Lightowler et al. (49) | 2010 | South Africa | 186 | CSe | 49.5 | 32 | 36 | 14.5% | CSF Culture/India ink | Amphotericin, Fluconazole | 33.9 |
| Gaskell et al. (50) | 2014 | Malawi | 58 | C | 51 | 35 | 36 | 45% | India Ink. CSF Culture | Fluconazole | 44.9 |
| Hiesgen et al. (51) | 2017 | South Africa | 87 | C | 55.2 | 34 | 52 | 44.8% | India Ink/CSF CRAG/CSF Culture | Amphotericin, Fluconazole | 31 |
| Bicanic et al. (52) | 2009 | Thailand, South Africa, Uganda | 262 | C | 45 | 33 | 26 | No data | CSF Culture | Amphotericin, Fluconazole, Flucytosine | 31 |
CSF, cerebral spinal fluid; CRAG, Cryptococcal antigen; ART, antiretroviral therapy; CD4, cluster of differentiation 4; CM, cryptococcal meningitis; CT, computerized tomography scan; CSF, cerebral spinal fluid;%, percentage; CS, Cross-sectional; C, Cohort; RCT, Randomized control trial; CSe, Case series.